top of page

10.1146/annurev-pharmtox-051921- 085407
10.3389/fimmu.2021.658840

Our mission is to provide pre-clinical stabilised lipoxin mimetics that can, because of shared mechanisms, serve as single interventions for the amelioration of multiple debilitating age related inflammatory diseases and enhance healthy longevity.
LipidEv's Lipoxin analogue / mimetics are now exclusively available globally from
For technical details contact
For related summaries of LipidEv's activities and products please see the open access reviews:
Ⓒ
LipidEv Ltd 2026
bottom of page
